Stay updated on Imatinib in Acute Ischaemic Stroke Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Acute Ischaemic Stroke Clinical Trial page.

Latest updates to the Imatinib in Acute Ischaemic Stroke Clinical Trial page
- Check4 days agoChange DetectedThe page now displays the Imatinib acute ischaemic stroke trial record, with its study design, eligibility criteria, outcome measures, contacts, and participating locations, instead of an access-denied error.SummaryDifference70%

- Check11 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0 while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedAn NIH-wide banner announces updates to terminology used across NIH content, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the trial content and preventing access to the study record. This indicates an availability issue rather than a substantive update to the study details.SummaryDifference19%

- Check60 days agoChange DetectedThe page now shows a revision bump to v3.7.0, indicating an update to the page rendering or underlying site components. It does not modify the study content, eligibility criteria, or trial results.SummaryDifference0.0%

Stay in the know with updates to Imatinib in Acute Ischaemic Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Acute Ischaemic Stroke Clinical Trial page.